Bayer Health Care: Application of the Accelerated Stability Assessment Program (ASAP) to a Liquid Dosage Form Containing Multiple Active Ingredients: A Case Study

Posted on November 28, 2016 in

Poster by Dr. Foyeke Badejo, AAPS 2016 (Denver)

ASAP study conducted in three weeks was used successfully to predict liquid drug product shelf-lives (25oC/60%RH). Moreover, the mechanistic insight gained helped to rationalize the impact of flavor components on the product.

Click here to view poster description.